2017 International Congress Archives - Page 124 of 155

Saliva changes and the oral health in Parkinson´s disease

J. Tiigimäe-Saar, T. Tamme, P. Taba (Tartu, Estonia)
Salivary Alpha-Synuclein in Aging

G. Vivacqua, A. Fabbrini, A. Suppa, R. Mancinelli, G. Fabbrini, C. Colosimo, A. Berardelli (Rome, Italy)
Salivary biomarkers for Huntington’s disease (HD)

J. Corey-Bloom, A. Aikin, S. Park, A. Haque, A. Nathan, D. Granger, S. Granger, E. Thomas (La Jolla, CA, USA)
Sample size estimation for clinical trials in de novo Parkinson’s disease (PD): Results from the Parkinson’s Progression Markers Initiative (PPMI) Study

T. Simuni, C. Caspell-Garcia, N. Seedorff, C. Coffey, S. Lasch, B. Mollenhauer, C. Tanner, K. Kieburtz, K. Marek (Chicago, IL, USA)
Saving Veterans Time, Miles, and Money: Cost Analysis of Video Telemedicine Evaluation of Deep Brain Stimulation (DBS) candidacy at the VA

N. Witek, S. Heath, C. Tanner, N. Galifianakis (San Francisco, CA, USA)
Screening of cognitive impairment in Huntington’s disease with the Parkinson’s Disease – Cognitive Rating Scale (PD-CRS)

S. Martinez-Horta, A. Horta-Barba, J. Perez-Perez, J. Pagonabarraga, J. Marin-Lahoz, J. Kulisevsky (Barcelona, Spain)
Screening of GBA and LRRK2 G2019S Mutations in Egyptian Parkinson’s Disease Patients

L. R'Bibo, S. Hamed, H. Houlden, N. Wood (London, United Kingdom)
Secondary Vascular Parkinsonism in Uzbekistan: Hormonal Pathogenetic Effects and Vascular-Immunological Basics.

D. Akramova (Tashkent, Uzbekistan)
Segregation of subjective and objective clinical measures in Parkinson’s disease

K. Markopoulou, R. Frigerio, A. Premkumar, B. Schoneburg, M. Dudek, S. Walters, C. Wang, D. Maraganore (Evanston, IL, USA)
Self Perception of Dysphagia in Parkinson Disease

A. Silbergleit, C. Sidiropoulos, R. Konnai, L. Schultz, A. Kitowski, P. LeWitt (West Bloomfield, MI, USA)